279 related articles for article (PubMed ID: 28794006)
1. Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.
Kim BR; Coyaud E; Laurent EMN; St-Germain J; Van de Laar E; Tsao MS; Raught B; Moghal N
Mol Cell Proteomics; 2017 Oct; 16(10):1864-1888. PubMed ID: 28794006
[TBL] [Abstract][Full Text] [Related]
2. SOX2 and PI3K Cooperate to Induce and Stabilize a Squamous-Committed Stem Cell Injury State during Lung Squamous Cell Carcinoma Pathogenesis.
Kim BR; Van de Laar E; Cabanero M; Tarumi S; Hasenoeder S; Wang D; Virtanen C; Suzuki T; Bandarchi B; Sakashita S; Pham NA; Lee S; Keshavjee S; Waddell TK; Tsao MS; Moghal N
PLoS Biol; 2016 Nov; 14(11):e1002581. PubMed ID: 27880766
[TBL] [Abstract][Full Text] [Related]
3. EP300 knockdown reduces cancer stem cell phenotype, tumor growth and metastasis in triple negative breast cancer.
Ring A; Kaur P; Lang JE
BMC Cancer; 2020 Nov; 20(1):1076. PubMed ID: 33167919
[TBL] [Abstract][Full Text] [Related]
4. SOX2 in squamous cell carcinoma: amplifying a pleiotropic oncogene along carcinogenesis.
Hussenet T; du Manoir S
Cell Cycle; 2010 Apr; 9(8):1480-6. PubMed ID: 20372069
[TBL] [Abstract][Full Text] [Related]
5. Sex-Determining Region Y-box 2 Promotes Growth of Lung Squamous Cell Carcinoma and Directly Targets Cyclin D1.
Li C; He B; Huang C; Yang H; Cao L; Huang J; Hu C
DNA Cell Biol; 2017 Apr; 36(4):264-272. PubMed ID: 28151013
[TBL] [Abstract][Full Text] [Related]
6. Bromodomain inhibition of the coactivators CBP/EP300 facilitate cellular reprogramming.
Ebrahimi A; Sevinç K; Gürhan Sevinç G; Cribbs AP; Philpott M; Uyulur F; Morova T; Dunford JE; Göklemez S; Arı Ş; Oppermann U; Önder TT
Nat Chem Biol; 2019 May; 15(5):519-528. PubMed ID: 30962627
[TBL] [Abstract][Full Text] [Related]
7. Cell surface marker profiling of human tracheal basal cells reveals distinct subpopulations, identifies MST1/MSP as a mitogenic signal, and identifies new biomarkers for lung squamous cell carcinomas.
Van de Laar E; Clifford M; Hasenoeder S; Kim BR; Wang D; Lee S; Paterson J; Vu NM; Waddell TK; Keshavjee S; Tsao MS; Ailles L; Moghal N
Respir Res; 2014 Dec; 15(1):160. PubMed ID: 25551685
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of a putative tumor suppressor BMP4 by SOX2 promotes growth of lung squamous cell carcinoma.
Fang WT; Fan CC; Li SM; Jang TH; Lin HP; Shih NY; Chen CH; Wang TY; Huang SF; Lee AY; Liu YL; Tsai FY; Huang CT; Yang SJ; Yen LJ; Chuu CP; Chen CY; Hsiung CA; Chang JY; Wang LH; Chang IS; Jiang SS
Int J Cancer; 2014 Aug; 135(4):809-19. PubMed ID: 24477565
[TBL] [Abstract][Full Text] [Related]
9. SOX2 promotes tumor growth of esophageal squamous cell carcinoma through the AKT/mammalian target of rapamycin complex 1 signaling pathway.
Gen Y; Yasui K; Nishikawa T; Yoshikawa T
Cancer Sci; 2013 Jul; 104(7):810-6. PubMed ID: 23510069
[TBL] [Abstract][Full Text] [Related]
10. SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma.
Fukazawa T; Guo M; Ishida N; Yamatsuji T; Takaoka M; Yokota E; Haisa M; Miyake N; Ikeda T; Okui T; Takigawa N; Maeda Y; Naomoto Y
Sci Rep; 2016 Feb; 6():20113. PubMed ID: 26846300
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma.
Liu Y; Yin N; Wang X; Khoor A; Sambandam V; Ghosh AB; Fields ZA; Murray NR; Justilien V; Fields AP
Cell Rep; 2020 Jan; 30(3):771-782.e6. PubMed ID: 31968252
[TBL] [Abstract][Full Text] [Related]
12. SOX2 amplification is a common event in squamous cell carcinomas of different organ sites.
Maier S; Wilbertz T; Braun M; Scheble V; Reischl M; Mikut R; Menon R; Nikolov P; Petersen K; Beschorner C; Moch H; Kakies C; Protzel C; Bauer J; Soltermann A; Fend F; Staebler A; Lengerke C; Perner S
Hum Pathol; 2011 Aug; 42(8):1078-88. PubMed ID: 21334718
[TBL] [Abstract][Full Text] [Related]
13. The Lineage-Defining Transcription Factors SOX2 and NKX2-1 Determine Lung Cancer Cell Fate and Shape the Tumor Immune Microenvironment.
Mollaoglu G; Jones A; Wait SJ; Mukhopadhyay A; Jeong S; Arya R; Camolotto SA; Mosbruger TL; Stubben CJ; Conley CJ; Bhutkar A; Vahrenkamp JM; Berrett KC; Cessna MH; Lane TE; Witt BL; Salama ME; Gertz J; Jones KB; Snyder EL; Oliver TG
Immunity; 2018 Oct; 49(4):764-779.e9. PubMed ID: 30332632
[TBL] [Abstract][Full Text] [Related]
14. The PRKCI and SOX2 oncogenes are coamplified and cooperate to activate Hedgehog signaling in lung squamous cell carcinoma.
Justilien V; Walsh MP; Ali SA; Thompson EA; Murray NR; Fields AP
Cancer Cell; 2014 Feb; 25(2):139-51. PubMed ID: 24525231
[TBL] [Abstract][Full Text] [Related]
15. Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung.
Yuan P; Kadara H; Behrens C; Tang X; Woods D; Solis LM; Huang J; Spinola M; Dong W; Yin G; Fujimoto J; Kim E; Xie Y; Girard L; Moran C; Hong WK; Minna JD; Wistuba II
PLoS One; 2010 Feb; 5(2):e9112. PubMed ID: 20161759
[TBL] [Abstract][Full Text] [Related]
16. SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity.
Nakatsugawa M; Takahashi A; Hirohashi Y; Torigoe T; Inoda S; Murase M; Asanuma H; Tamura Y; Morita R; Michifuri Y; Kondo T; Hasegawa T; Takahashi H; Sato N
Lab Invest; 2011 Dec; 91(12):1796-804. PubMed ID: 21931300
[TBL] [Abstract][Full Text] [Related]
17. SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin.
Ferone G; Song JY; Sutherland KD; Bhaskaran R; Monkhorst K; Lambooij JP; Proost N; Gargiulo G; Berns A
Cancer Cell; 2016 Oct; 30(4):519-532. PubMed ID: 27728803
[TBL] [Abstract][Full Text] [Related]
18. CDK1 promotes the stemness of lung cancer cells through interacting with Sox2.
Huang Z; Shen G; Gao J
Clin Transl Oncol; 2021 Sep; 23(9):1743-1751. PubMed ID: 33721187
[TBL] [Abstract][Full Text] [Related]
19. SOX2 is an oncogene activated by recurrent 3q26.3 amplifications in human lung squamous cell carcinomas.
Hussenet T; Dali S; Exinger J; Monga B; Jost B; Dembelé D; Martinet N; Thibault C; Huelsken J; Brambilla E; du Manoir S
PLoS One; 2010 Jan; 5(1):e8960. PubMed ID: 20126410
[TBL] [Abstract][Full Text] [Related]
20. BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.
Dingar D; Kalkat M; Chan PK; Srikumar T; Bailey SD; Tu WB; Coyaud E; Ponzielli R; Kolyar M; Jurisica I; Huang A; Lupien M; Penn LZ; Raught B
J Proteomics; 2015 Apr; 118():95-111. PubMed ID: 25452129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
